Cargando…
Nebulized colistin for treatment of ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: we still need to straighten out the dose!
Autores principales: | Honore, Patrick M., Jacobs, Rita, Hendrickx, Inne, De Waele, Elisabeth, De Regt, Jouke, Spapen, Herbert D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482201/ https://www.ncbi.nlm.nih.gov/pubmed/26113262 http://dx.doi.org/10.1186/s13054-015-0966-x |
Ejemplares similares
-
Colistin dosing for treatment of multidrug-resistant Pseudomonas in critically ill patients - please, be adequate!
por: Honoré, Patrick M, et al.
Publicado: (2014) -
Higher colistin dose during continuous renal replacement therapy: look before leaping!
por: Honore, Patrick M., et al.
Publicado: (2015) -
‘Biomarking’ infection during continuous renal replacement therapy: still relevant?
por: Honore, Patrick M, et al.
Publicado: (2015) -
Biomarkers in critical illness: have we made progress?
por: Honore, Patrick M, et al.
Publicado: (2016) -
High-frequency percussive ventilation in acute respiratory distress syndrome: knocking at the door but can it be let in?
por: Spapen, Herbert, et al.
Publicado: (2018)